SCHEMBL5117468

SCHEMBL5117468

CNc1c(-c2ccc(C#Cc3ccccn3)s2)nc2cnccn12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 11/20 0.39
KDM4E B2RXH2 5/20 0.39
LMNA P02545 4/20 0.39
MAPK1 P28482 3/20 0.39
ALDH1A1 P00352 5/20 0.37
HPGD P15428 3/20 0.37
HSD17B10 Q99714 2/20 0.37
ALOX15 P16050 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
BRAF P15056 2/20 0.36
CDK9 P50750 1/20 0.36
MAPT P10636 10/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GFER P55789 1/20 0.36
TP53 P04637 4/20 0.36
SALL4 Q9UJQ4 1/20 0.35
HTT P42858 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5123348 0.89 SALL4 (0.48) GAAKDM4ELMNAMAPK1ALDH1A1
Hydrochloric Acid SCHEMBL5124088 0.89 SALL4 (0.47) GAAKDM4ELMNAMAPK1ALDH1A1
SCHEMBL5113507 0.87 GAA (0.43) GAAKDM4ELMNAMAPK1ALDH1A1
SCHEMBL5114939 0.85 GRM5 (0.34) GAAKDM4ELMNAMAPK1ALDH1A1
SCHEMBL5127776 0.85 GAA (0.47) GAAKDM4ELMNAMAPK1ALDH1A1
Hydrochloric Acid SCHEMBL5128203 0.85 GRM5 (0.33) GAAKDM4ELMNAMAPK1ALDH1A1
SCHEMBL5121700 0.84 GAA (0.34) GAAKDM4ELMNAMAPK1ALDH1A1
SCHEMBL5115068 0.82 GAA (0.35) GAAKDM4ELMNAMAPK1ALDH1A1
SCHEMBL5128565 0.79 SALL4 (0.45) GAAKDM4ELMNAMAPK1ALDH1A1
SCHEMBL5263148 0.78 SALL4 (0.48) GAAKDM4ELMNAMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1791840-B1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS GRUENENTHAL GMBH (DE) 2013-11-27 EP claimed
US-7420056-B2 Substituted bicyclic imidazo-3-ylamine compounds GRUENENTHAL GMBH (DE) 2008-09-02 US claimed
US-20070155965-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS GRUENENTHAL GMBH. (DE) 2007-07-05 US claimed
EP-1791840-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2007-06-06 EP claimed
WO-2006029980-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2006-03-23 WO claimed
US-7420056-B2 Substituted bicyclic imidazo-3-ylamine compounds GRUENENTHAL GMBH (DE) 2008-09-02 US disclosed
US-20070155965-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS GRUENENTHAL GMBH. (DE) 2007-07-05 US disclosed
EP-1791840-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2007-06-06 EP disclosed
WO-2006029980-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155965-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS AADAC, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAICS GAA 234/4885KDM4E 1336/4885LMNA 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.